secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lexeo Therapeutics, Inc. (LXEO)
CIK:        0001907108
Form:       8-K
Filed at:   2024-04-22T23:59:59+00:00
Accession:  0000950123-24-003417
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Bernard Davitian will not stand for reelection at Lexeo's 2024 annual meeting
--------------------------------------------------------------------------------

- Bernard Davitian notified Lexeo on April 16, 2024, that he will not seek reelection.
- His departure is effective at the June 25, 2024 annual meeting of stockholders.
- The decision is not due to any disagreement with the company's operations or policies.
- No replacement director has been announced at this time.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1907108/000095012324003417/0000950123-24-003417-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1907108/000095012324003417/lxeo-20240422.htm
  HTML page:      https://secwatch.observer/filing/0000950123-24-003417

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer